WEDNESDAY, April 26, 2023 (HealthDay News) — An extended-release version of a Parkinson’s disease drug could provide more stable relief for patients with the movement disorder, new clinical trial data show. The new formulation of levodopa, called IPX203, extended the duration of patients’ “on time” — the amount of timeContinue Reading

TUESDAY, April 25, 2023 (HealthDay News) — Each year, about 140 kids in the United States are diagnosed with a craniopharyngioma, a typically non-cancerous brain tumor that develops near the pituitary gland at the base of the brain. Doctors treat craniopharyngiomas with surgery to remove the entire tumor or aContinue Reading

TUESDAY, April 25, 2023 (HealthDay News) — People with cerebral palsy are more likely to be prescribed opioids to manage pain, making them vulnerable to the ongoing opioid crisis in the United States, according to a new study. While pain is common among patients with cerebral palsy, opioids may notContinue Reading

MONDAY, April 24, 2023 (HealthDay News) — Researchers studying how tiny plastic particles can breach the protective blood-brain barrier report they have found that answer, thanks to mice and computer modeling. “With the help of computer models, we discovered that a certain surface structure [biomolecularcorona] was crucial in enabling plasticContinue Reading